Study Name: An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5
11 locations found
- Pfizer Investigational Site
Location: Wilmington, Delaware 19803
- Pfizer Investigational Site
Location: Washington, District of Columbia 20010
- Pfizer Investigational Site
Location: Jacksonville, Florida 32209
- Pfizer Investigational Site
Location: Miami, Florida 33136
- Pfizer Investigational Site
Location: Richmond, Virginia 23298
- Pfizer Investigational Site
Location: Phoenix, Arizona 85016
- Pfizer Investigational Site
Location: Los Angeles, California 90027
- Pfizer Investigational Site
Location: Orange, California 92868
- Pfizer Investigational Site
Location: St Petersburg, Florida 33701
- Pfizer Investigational Site
Location: Tampa, Florida 33612
- Pfizer Investigational Site
Location: Houston, Texas 77030
|